Evidence map›Paper›PMID 30036277›Full record

Observational studyJournal of acquired immune deficiency syndromes (1999)2018

Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV.

Joseph A Delaney, Robin M Nance, Bridget M Whitney, Frederick L Altice, Xinyuan Dong, Maria Esther Perez Trejo, Mika Matsuzaki, Faye S Taxman, Geetanjali Chander, Irene Kuo and 13 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Journal of acquired immune deficiency syndromes (1999), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Impact of Depressive Symptom Severity on Stroke Risk in a US Cohort of People with HIV.Journal of acquired immune deficiency syndromes (1999) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Impact of Abstinence and of Reducing Illicit Drug Use Without Abstinence on Human Immunodeficiency Virus Viral Load.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 1 country.

Joseph A DelaneyEpidemiology, University of Washington, Seattle, WA.
Robin M NanceEpidemiology, University of Washington, Seattle, WA.
Bridget M WhitneyEpidemiology, University of Washington, Seattle, WA.
Frederick L AlticeMedicine and Epidemiology, Yale School of Medicine, New Haven, CT.
Xinyuan DongBiostatistics, University of Washington, Seattle, WA.
Maria Esther Perez TrejoBiostatistics, University of Washington, Seattle, WA.
Mika MatsuzakiBiostatistics, University of Washington, Seattle, WA.
Faye S TaxmanCriminology, Law and Society, George Mason University, Fairfax, VA.
Geetanjali ChanderMedicine and Epidemiology, Johns Hopkins University, Baltimore, MD.
Irene KuoEpidemiology, Johns Hopkins University, Baltimore, MD.
Rob FredericksenMedicine, University of Washington, Seattle, WA.
Lauren N StrandPharmacy, University of Washington, Seattle, WA.
Joseph J EronMedicine and Epidemiology, University of North Carolina, Chapel Hill, NC.
Elvin GengMedicine, University of California San Francisco, San Francisco, CA.
Mari M KitahataMedicine, University of Washington, Seattle, WA.
William C MathewsClinical Medicine, University of California San Diego, San Diego, CA.
Kenneth MayerGlobal Health and Population, Harvard University, Boston, MA.
Richard D MooreMedicine, Johns Hopkins University, Baltimore, MD.
Michael S SaagMedicine, University of Alabama, Birmingham, AL.
Sandra SpringerMedicine and Nursing, Yale School of Medicine, New Haven, CT.
Redonna ChandlerNational Institute of Drug Abuse, Washington, DC.
Shoshana KahanaNational Institute of Drug Abuse, Washington, DC.
Heidi M CraneMedicine, University of Washington, Seattle, WA.
University of Washington · USJohns Hopkins University · USNational Institute on Drug Abuse · USYale University · USGeorge Mason University · USHarvard University · USUniversity of Alabama at Birmingham · USUniversity of California, San Diego · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI E. Jennifer Edelman · 2001 to 2026
$48.5M
Johns Hopkins HIV Clinical CohortU01DA036935 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2014 to 2024
$14.9M
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)U01AA020793 · NIAAA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., LAU, BRYAN · 2011 to 2020
$5.8M
Substance use patterns and contexts: impact on epigenetic age and prevention strategies in an HIV clinical care cohortR01DA047045 · NIDA · UNIVERSITY OF WASHINGTON · PI Heidi M. Crane, Joseph Austin Delaney · 2018 to 2026
$5.1M
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patientsR01HL126538 · NHLBI · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., CROTHERS, KRISTINA ANNE · 2015 to 2025
$5.1M
Integration of Evidence-based Alcohol Interventions into HIV CareU01AA020802 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CROPSEY, KAREN L, MUGAVERO, MICHAEL J · 2011 to 2020
$4.2M
HIV, Buprenorphine, and the Criminal Justice SystemR01DA030768 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2010 to 2015
$4.0M
NHLBI NIH HHS R01 HL126538NIAAA NIH HHS U01 AA020793NIAAA NIH HHS U01 AA020802NIAAA NIH HHS U24 AA020801NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI094189NIAID NIH HHS R24 AI067039NIDA NIH HHS R01 DA030768NIDA NIH HHS R01 DA047045NIDA NIH HHS U01 DA036935NIDA NIH HHS U01 DA037702NIMH NIH HHS P30 MH062294
6 · The paper itself

Abstract

purposeSubstance use is linked with poor outcomes among people living with HIV (PLWH) and is associated with mental health disorders. This analysis examines the impact of decreasing substance use, even without abstinence, on depressive symptoms among PLWH.

methodsData are from PLWH enrolled in the Centers for AIDS Research Network of Integrated Clinical Sites cohort. Participants completed longitudinal assessments of substance use (modified ASSIST) and depressive symptoms (PHQ-9). Changes in substance use frequency were categorized as abstinence, reduced use, and nondecreasing use. Adjusted linear mixed models with time-updated change in substance use frequency and depressive symptom scores were used to examine associations between changes in the use of individual substances and depressive symptoms. Analyses were repeated using joint longitudinal survival models to examine associations with a high (PHQ-9 ≥10) score.

resultsAmong 9905 PLWH, 728 used cocaine/crack, 1016 used amphetamine-type substances (ATS), 290 used illicit opiates, and 3277 used marijuana at baseline. Changes in ATS use were associated with the greatest improvements in depressive symptoms: stopping ATS led to a mean decrease of PHQ-9 by 2.2 points (95% CI: 1.8 to 2.7) and a 61% lower odds of PHQ-9 score ≥10 (95% CI: 0.30 to 0.52), and decreasing ATS use led to a mean decrease of 1.7 points (95% CI: 1.2 to 2.3) and a 62% lower odds of PHQ-9 score ≥10 (95% CI: 0.25 to 0.56). Stopping and reducing marijuana and stopping cocaine/crack use were also associated with improvement in depressive symptoms.

conclusionsWe demonstrated that both substance use reduction and abstinence are associated with improvements in depressive symptoms over time.

Indexed as

AdolescentAdultAgedAged, 80 and overDepressionDrug UtilizationFemaleHIV InfectionsHumansIllicit DrugsLongitudinal StudiesMaleMiddle AgedYoung AdultIllicit Drugs

Identifiers

PMID30036277
PMCPMC6681811
OpenAlexW2883979886

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.